Researchers at the University of Arizona are working on a promising treatment to reduce the risk of dementia in patients who have had a stroke. Kristian Doyle, associate professor of immunobiology, University of Arizona College of Medicine - Tucson, said they are investigating a drug that helps the brain safely store cholesterol after a stroke without provoking an inflammatory response.

Researchers will use a $1.6 million National Eye Institute grant to study age-related lens cell changes that can lead to cataracts.

The two poison centers in Arizona have seen a significant increase in poisonings related to fentanyl from illicit M30 tablets. These counterfeit pills are very dangerous and can be so toxic they cause death. Steve Dudley, PharmD, DABAT, clinical toxicologist and director of the UArizona Poison and Drug Information Center, is quoted.

SARS-CoV-2 has given scientists a plethora of vaccines to evaluate. The response after the Johnson & Johnson vaccine, for instance, elicits a weaker immune response than the mRNA vaccines initially, “and then it actually starts to get better over time,” says Deepta Bhattacharya, PhD, a professor and immunologist at the College of Medicine – Tucson.

University of Arizona Health Sciences researchers discovered a potential treatment to reduce the risk of post-stroke dementia, which may be influenced by the immune response to dead brain tissue left in the wake of a stroke, according to a study published in the Journal of Neuroscience.

Solutions require complex, sustained effort to move the mountain of historical racism in medicine and the systemic ways it may exhibit itself today.

This free service is part of a research project on fatty liver, particularly non-alcoholic, at the Mel and Enid Zuckerman Arizona College of Public Health, which seeks to estimate the presence of scarring and fat in the liver of Hispanic inhabitants of Southern Arizona.